Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
Details
Download: 33091381_BIB_6F92D71268C4.pdf (317.84 [Ko])
State: Public
Version: Final published version
License: Not specified
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_6F92D71268C4
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
Journal
Cancer cell
ISSN
1878-3686 (Electronic)
ISSN-L
1535-6108
Publication state
Published
Issued date
09/11/2020
Peer-reviewed
Oui
Volume
38
Number
5
Pages
602-604
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.
Keywords
Betacoronavirus/isolation & purification, COVID-19, Clinical Decision-Making, Coronavirus Infections/complications, Coronavirus Infections/virology, Global Burden of Disease/standards, Humans, International Cooperation, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/virology, Practice Guidelines as Topic/standards, Registries, SARS-CoV-2, Thoracic Neoplasms/epidemiology, Thoracic Neoplasms/therapy, Thoracic Neoplasms/virology
Pubmed
Web of science
Open Access
Yes
Create date
02/11/2020 14:40
Last modification date
30/04/2021 7:11